DORMATARG, INC.

Basic Information

3117 CASTLEROCK RD
OKLAHOMA CITY, OK, 73120-1817

Company Profile

n/a

Additional Details

Field Value
DUNS: 808090497
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Identifying the drug target in dormant cancer cells

    Amount: $296,937.00

    DESCRIPTION (provided by applicant): In spite of billions of dollars spent in the War on Cancer, cancer-specific mortality has changed little as a result, and the vast majority of cures are produced s ...

    SBIR Phase I 2012 Department of Health and Human Services
  2. Drugs Targeting Dormant Tumors as Anti-Metastatic Agents

    Amount: $1,991,632.00

    DESCRIPTION (provided by applicant): Most patients with solid tumors die of tumor recurrence at the same site or metastasis of the tumor to distal sites. An intermediate step in both recurrence and me ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. Preventing bladder cancer recurrence and metastasis

    Amount: $259,133.00

    DESCRIPTION (provided by applicant): Bladder cancer kills approximately 13,000 Americans per year. At least half of these deaths are preventable with no improvements in screening because they occur in ...

    SBIR Phase I 2009 Department of Health and Human Services
  4. Drugs Targeting Dormant Tumors as Anti-Metastatic Agents

    Amount: $122,450.00

    DESCRIPTION (provided by applicant): Most cancer deaths occur from metastatic tumors rather than from the primary tumor alone. Although many of the new drugs in the past decade are directed against tu ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government